Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
16,593,252
-
Share change
-
+16,593,162
-
Total reported value
-
$352,567,000
-
Price per share
-
$21.40
-
Number of holders
-
31
-
Value change
-
+$352,564,998
-
Number of buys
-
30
Institutional Holders of CYTEIR THERAPEUTICS INC - COM (CYTT) as of Q2 2021
As of 30 Jun 2021 CYTEIR THERAPEUTICS INC - COM (CYTT) had 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 16,593,252 shares of stock of the company.
Largest 10 holders included Novo Holdings A/S, RA CAPITAL MANAGEMENT, L.P., JANUS HENDERSON GROUP PLC, Avidity Partners Management LP, FMR LLC, BAKER BROS. ADVISORS LP, Ally Bridge Group (NY) LLC, CAAS CAPITAL MANAGEMENT LP, ACUTA CAPITAL PARTNERS, LLC, and Sofinnova Investments, Inc..
This table shows 31 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.